RecruitingNot ApplicableNCT04938986
Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer
Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer : Prospective Cohort Comparing the Recommandation for Patient Care According to the Immunoscore® With the Standard Care Decision.
Sponsor
Hospital St. Joseph, Marseille, France
Enrollment
100 participants
Start Date
Apr 4, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluate the patient care recommandation induced by the IMMUNOSCORE® result
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria8
- age between 18 and 80 inclusive;
- histologically confirmed colon adenocarcinoma;
- having undergone a curative resection of stage I, II or III colorectal cancer;
- diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2;
- eligible to receive 6 months of adjuvant chemotherapy;
- having given free, informed and written consent;
- agreeing to the use of a tumor sample for research purposes;
- being affiliated to a social security system.
Exclusion Criteria4
- pregnant or breastfeeding women
- legal incapacity or physical, psychological, social or geographical conditions preventing the patient from signing the consent or completing the study.
- history of other solid tumor within 3 years before inclusion, with the exception of in-situ cancer of the cervix and skin cancers (basal or squamous) treated and controlled
- person subject to a safeguard measure.
Interventions
DIAGNOSTIC_TESTIMMUNOSCORE®
recommendation for patient care according to the result of the IMMUNOSCORE®
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04938986